| scholarly article | Q13442814 |
| P50 | author | Bess Dawson-Hughes | Q47171574 |
| Anastassios G Pittas | Q100453450 | ||
| P2093 | author name string | Susan S Harris | |
| Paul Stark | |||
| Myrto Eliades | |||
| P2860 | cites work | Endocrine regulation of energy metabolism by the skeleton | Q22337453 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass | Q28505908 | ||
| Leptin regulation of bone resorption by the sympathetic nervous system and CART | Q28589974 | ||
| Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone | Q28646319 | ||
| Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older | Q34437473 | ||
| Adipocytokines and insulin resistance | Q35649614 | ||
| Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins | Q36322457 | ||
| Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice | Q36516140 | ||
| Convergence between bone and energy homeostases: leptin regulation of bone mass | Q36644728 | ||
| Serum leptin level is a regulator of bone mass | Q36855076 | ||
| Reciprocal regulation of bone and energy metabolism | Q37136921 | ||
| Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone | Q38286632 | ||
| Gla-containing proteins of bone | Q38748938 | ||
| The Physical Activity Scale for the Elderly (PASE): development and evaluation | Q39605927 | ||
| High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis | Q39996770 | ||
| C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women | Q40608305 | ||
| Increased bone formation in osteocalcin-deficient mice. | Q41182577 | ||
| Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices. | Q42439097 | ||
| Precision and stability of dual-energy X-ray absorptiometry measurements | Q43589969 | ||
| Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements | Q44424865 | ||
| Bone metabolism in male patients with type 2 diabetes | Q45300536 | ||
| Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus | Q46433525 | ||
| Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people | Q46827195 | ||
| Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats. | Q46883073 | ||
| Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus | Q47760653 | ||
| Determinants and correlates of serum undercarboxylated osteocalcin. | Q50648542 | ||
| The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. | Q51479096 | ||
| Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. | Q51555713 | ||
| Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications | Q68104233 | ||
| Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus | Q72149698 | ||
| Osteoporosis in older adults with non-insulin-dependent diabetes mellitus: is it sex related? | Q73140761 | ||
| Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women | Q80535508 | ||
| A skeleton key to metabolism | Q81165548 | ||
| Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts | Q81408826 | ||
| Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk | Q83877141 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| clinical chemistry | Q849994 | ||
| osteocalcin | Q59250722 | ||
| P304 | page(s) | 827-32 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Association between serum osteocalcin and markers of metabolic phenotype | |
| P478 | volume | 94 |
| Q36037135 | A common polymorphism rs1800247 in osteocalcin gene is associated with hypertension and diastolic blood pressure levels: the Shanghai Changfeng study |
| Q34742767 | A cross-sectional study of osteocalcin and body fat measures among obese adolescents |
| Q43741405 | A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss |
| Q36886615 | A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms |
| Q39707660 | A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort |
| Q37365294 | A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease. |
| Q34334299 | Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study |
| Q28080748 | Adipose tissue dysfunction and its effects on tumor metabolism |
| Q34016508 | Age and menopausal status affect osteoprotegerin and osteocalcin levels in women differently, irrespective of thyroid function |
| Q34033108 | An ELISA-based method to quantify osteocalcin carboxylation in mice |
| Q37789470 | An evolving integrative physiology: skeleton and energy metabolism |
| Q37942705 | An old friend in a new light: the role of osteocalcin in energy metabolism |
| Q38690915 | An overview of osteocalcin progress |
| Q35804646 | Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes. |
| Q33557227 | Association analysis of genetic polymorphisms and potential interaction of the osteocalcin (BGP) and ER-alpha genes with body mass index (BMI) in premenopausal Chinese women |
| Q36801946 | Association between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients with Type 2 Diabetes |
| Q51364827 | Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. |
| Q38617812 | Association between serum osteocalcin and body mass index: a systematic review and meta-analysis. |
| Q84550959 | Association of bone turnover markers with mortality in men referred to coronary angiography |
| Q50899799 | Association of bone turnover markers with mortality in women referred to coronary angiography: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. |
| Q36538444 | Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men |
| Q36354495 | Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults |
| Q37686333 | Associations among osteocalcin, leptin and metabolic health in children ages 9-13 years in the United States |
| Q36982011 | Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults |
| Q57313042 | Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study |
| Q35595130 | Bone Mineral Content as a Driver of Energy Expenditure in Prepubertal and Early Pubertal Boys |
| Q34160465 | Bone and glucose metabolism: a two-way street |
| Q38262674 | Bone as an endocrine organ relevant to diabetes |
| Q35825346 | Bone fragility in type 2 diabetes mellitus |
| Q42361203 | Bone mineral density and risk of type 2 diabetes and coronary heart disease: A Mendelian randomization study. |
| Q34894306 | Carbohydrate metabolism and the skeleton: picking a bone with the beta-cell |
| Q40046970 | Carboxylated and intact osteocalcin predict adiponectin concentration in hemodialyzed patients. |
| Q33683813 | Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children |
| Q35597885 | Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). |
| Q35664743 | Changes in Bone Biomarkers, BMC, and Insulin Resistance Following a 10-Week Whole Body Vibration Exercise Program in Overweight Latino Boys |
| Q37222124 | Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala). |
| Q89532420 | Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients |
| Q35831144 | Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. |
| Q36181331 | Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study |
| Q34143285 | Co-dependence of bone and energy metabolisms |
| Q35001847 | Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism |
| Q53742500 | Crosstalk Between Bone and Fat Tissue: Associations Between Vitamin D, Osteocalcin, Adipokines, and Markers of Glucose Metabolism Among Adolescents. |
| Q41189137 | Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis. |
| Q35059720 | Depression and osteoporosis: a research synthesis with meta-analysis |
| Q34015927 | Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes |
| Q33588822 | Differential pattern for regulating insulin secretion, insulin resistance, and lipid metabolism by osteocalcin in male and female T2DM patients |
| Q33954902 | Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). |
| Q37554936 | Do metabolic syndrome and its components have an impact on bone mineral density in adolescents? |
| Q34308143 | Effect of phylloquinone supplementation on glucose homeostasis in humans |
| Q35133159 | Effect of weight loss on serum osteocalcin and its association with serum adipokines |
| Q37232458 | Effects of 12-week exercise training on osteocalcin, high-sensitivity C-reactive protein concentrations, and insulin resistance in elderly females with osteoporosis |
| Q43461322 | Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. |
| Q34316048 | Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial |
| Q35908596 | Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus |
| Q34161867 | Emerging therapeutic opportunities for skeletal restoration |
| Q36853527 | Endocrine actions of osteocalcin |
| Q36539670 | Energy metabolism and the skeleton: Reciprocal interplay |
| Q36866334 | Fat targets for skeletal health |
| Q35841927 | FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis |
| Q35587183 | FoxO1, the transcriptional chief of staff of energy metabolism |
| Q37871942 | FoxO1: a molecule for all seasons |
| Q37511845 | Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences |
| Q37613880 | GPRC6A: Jack of all metabolism (or master of none). |
| Q37388026 | Gamma-carboxylation of osteocalcin and insulin resistance in older men and women |
| Q35446680 | Gender dimorphism and lack of day/night variation or effects of energy deprivation on undercarboxylated osteocalcin levels in humans |
| Q36850959 | Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism |
| Q36594167 | Glucose-loading reduces bone remodeling in women and osteoblast function in vitro |
| Q35895811 | Higher daily physical activity is associated with higher osteocalcin levels in adolescents |
| Q92510451 | Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells |
| Q97418728 | Humanized GPRC6AKGKY is a gain-of-function polymorphism in mice |
| Q37372871 | In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice |
| Q24629773 | Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition |
| Q34021680 | Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism |
| Q33935397 | Integrative physiology: defined novel metabolic roles of osteocalcin. |
| Q35811386 | Interactions between Serum Adipokines and Osteocalcin in Older Patients with Hip Fracture |
| Q35235417 | Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice |
| Q44090849 | Interplay between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism |
| Q36751951 | Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels |
| Q36203043 | Lifestyle-Related Metabolic Disorders, Osteoporosis, and Fracture Risk in Asia: A Systematic Review |
| Q37060844 | Low osteocalcin level is a risk factor for impaired glucose metabolism in a Chinese male population |
| Q35101774 | Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function |
| Q28068109 | Mechanisms involved in altered bone metabolism in diabetes: a narrative review |
| Q51343445 | Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations. |
| Q39176937 | Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin. |
| Q26862997 | Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks |
| Q28067712 | Novel biological markers of bone: from bone metabolism to bone physiology |
| Q33572134 | Novel bone endocrine networks integrating mineral and energy metabolism |
| Q38186619 | Nutrients other than carbohydrates: their effects on glucose homeostasis in humans |
| Q61217312 | Obesity and Glucose Metabolism |
| Q26771411 | Osteocalcin as a hormone regulating glucose metabolism |
| Q43007051 | Osteocalcin as a negative regulator of serum leptin concentration in humans: insight from triathlon competitions. |
| Q46480326 | Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study. |
| Q90248513 | Osteocalcin does not influence acute or chronic inflammation in human vascular cells |
| Q60673576 | Osteocalcin increase after bariatric surgery predicts androgen recovery in hypogonadal obese males |
| Q45024443 | Osteocalcin is independently associated with body mass index in adolescent girls |
| Q50972340 | Osteocalcin is not a strong determinant of serum testosterone and sperm count in men from infertile couples. |
| Q33556735 | Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus |
| Q45346518 | Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes |
| Q38244162 | Osteocalcin, energy and glucose metabolism. |
| Q51352515 | Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese. |
| Q86199274 | Osteocalcin, under-carboxylated osteocalcin and osteopontin are not associated with gestational diabetes mellitus but are inversely associated with leptin in non-diabetic women |
| Q38611641 | Osteocalcin-dependent regulation of glucose metabolism and fertility: Skeletal implications for the development of insulin resistance |
| Q38270450 | Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism |
| Q51371881 | Osteoid osteoma is an osteocalcinoma affecting glucose metabolism. |
| Q92356433 | Osteokines and the vasculature: a review of the in vitro effects of osteocalcin, fibroblast growth factor-23 and lipocalin-2 |
| Q33891378 | Osteoporosis, fractures, and diabetes |
| Q37156206 | Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance |
| Q21091051 | Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo/JngJ mice |
| Q39276537 | Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism |
| Q34623146 | Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania |
| Q53634487 | Regulation of Glucose Handling by the Skeleton: Insights From Mouse and Human Studies. |
| Q37882008 | Regulation of glucose metabolism and the skeleton |
| Q48718660 | Relationship between plasma osteocalcin, glycaemic control and components of metabolic syndrome in adult Nigerians with type 2 diabetes mellitus. |
| Q51386824 | Relationship between serum osteocalcin and glycaemic variability in Type 2 diabetes |
| Q37291180 | Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China |
| Q51351426 | Relationship of serum osteocalcin levels with blood glucose, insulin resistance and lipid profile in central Indian men with type 2 diabetes. |
| Q36509514 | Relationships between osteocalcin, glucose metabolism, and adiponectin in obese children: Is there crosstalk between bone tissue and glucose metabolism? |
| Q47406102 | Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults. |
| Q36249599 | Serum Osteocalcin Is Associated with Inflammatory Factors in Metabolic Syndrome: A Population-Based Study in Chinese Males |
| Q51374416 | Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. |
| Q37587460 | Serum levels of undercarboxylated osteocalcin are related to cardiovascular risk factors in patients with type 2 diabetes mellitus and healthy subjects. |
| Q34129927 | Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome |
| Q42910767 | Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men |
| Q37488676 | Serum osteocalcin is significantly related to indices of obesity and lipid profile in Malaysian men |
| Q45854695 | Serum osteocalcin levels are inversely associated with abdominal aortic calcification in men with type 2 diabetes mellitus |
| Q34664556 | Serum osteocalcin levels are inversely associated with plasma glucose and body mass index in healthy Chinese women |
| Q39017503 | Serum undercarboxylated osteocalcin correlates with hemoglobin A1c in children with recently diagnosed pediatric diabetes. |
| Q38475844 | Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study |
| Q51406314 | Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. |
| Q35668413 | Significant association between body composition phenotypes and the osteocalcin genomic region in normative human population |
| Q44552901 | Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients |
| Q35250223 | Skeleton and glucose metabolism: a bone-pancreas loop |
| Q37233575 | Suitable bone markers assessing bone status in patients with both coronary artery disease and diabetes |
| Q46767333 | Testosterone levels following decreases in serum osteocalcin |
| Q27012497 | The alliance of mesenchymal stem cells, bone, and diabetes |
| Q82862340 | The association between serum osteocalcin levels and metabolic syndrome in Koreans |
| Q35737624 | The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance. |
| Q43990101 | The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women: a double-blind randomized controlled clinical trial |
| Q51316512 | The effects of aerobic exercise training on serum osteocalcin, adipocytokines and insulin resistance on obese young males. |
| Q38844840 | The effects of muscle contraction and recombinant osteocalcin on insulin sensitivity ex vivo. |
| Q42660007 | The impact of type 2 diabetes on bone metabolism |
| Q33703058 | The influence of thyroid function and bone turnover on lipoprotein profile in young physically active men with different insulin sensitivity |
| Q35636353 | The role of osteocalcin in human glucose metabolism: marker or mediator? |
| Q37866694 | The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism |
| Q47265498 | The rs2274911 polymorphism in GPRC6A gene is associated with insulin resistance in normal weight and obese subjects. |
| Q38050402 | The skeleton as an endocrine organ |
| Q28263140 | The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects |
| Q35391518 | The use of alendronate is associated with a decreased incidence of type 2 diabetes mellitus--a population-based cohort study in Taiwan. |
| Q34712893 | Total and carboxylated osteocalcin associate with insulin levels in young adults born with normal or very low birth weight |
| Q89388766 | Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity |
| Q36068814 | Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease |
| Q53803853 | Undercarboxylated osteocalcin is associated with insulin resistance, but not adiponectin, during pregnancy. |
| Q36135154 | Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school children |
| Q36828712 | Vitamin K-dependent carboxylation of osteocalcin: friend or foe? |
| Q47185533 | Vitamin K-induced effects on body fat and weight: results from a 3-year vitamin K2 intervention study |
| Q36234492 | Whole body vibration therapy: a novel potential treatment for type 2 diabetes mellitus |
Search more.